e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

35.87 -0.40 (-1.10%)

Streaming Delayed Price Updated: 2:18 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Collegium Pharmaceutical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference

November 22, 2022

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Reports Third Quarter 2022 Financial Results

November 03, 2022

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022

October 20, 2022

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve ↗

August 08, 2022

Via Benzinga

Recap: Collegium Pharmaceutical Q1 Earnings ↗

May 10, 2022

Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Collegium Pharmaceutical's Shares Are Trading Higher Today ↗

April 05, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗

August 08, 2022

Via Benzinga

7 Micro-Cap Stocks to Take a Chance on Now ↗

June 04, 2022

Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors.

Via InvestorPlace

A Preview Of Collegium Pharmaceutical's Earnings ↗

May 09, 2022

Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

May 09, 2022

What Defines a Value Stock?

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

May 02, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Analyst Ratings For Collegium Pharmaceutical ↗

April 06, 2022

Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

February 15, 2022

JP Morgan raised Ralph Lauren Corporation (NYSE: RL) price target from $137 to $142. Ralph Lauren shares rose 1.2% to $124.00 in pre-market trading.

Via Benzinga

52 Biggest Movers From Yesterday ↗

February 15, 2022

Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences...

Via Benzinga

BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today ↗

February 14, 2022

Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal.

Via InvestorPlace

32 Stocks Moving In Monday's Mid-Day Session ↗

February 14, 2022

Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60...

Via Benzinga

Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal ↗

February 14, 2022

Collegium Pharmaceutical Inc (NASDAQ: COLL) will acquire BioDelivery Sciences International Inc (NASDAQ: BDSI) at $5.60 per share in an all-cash transaction,...

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

February 07, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

January 03, 2022

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Collegium Pharmaceutical, inc (COLL) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

COLL earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

5 Value Stocks To Watch In The Healthcare Sector ↗

October 11, 2021

The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may...

Via Benzinga

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

August 30, 2021

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 17, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...

Via Benzinga

Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet ↗

August 16, 2021

Toward the end of trading Monday, the Dow traded up 0.03% to 35,526.99 while the NASDAQ fell 0.34% to 14,771.91. The S&P also rose, gaining 0.02% to 4,468.88. The U.S. has the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 16, 2021

Gainers NanoVibronix (NASDAQ:NAOV) stock rose 44.04% to $3.63 during Monday's regular session. The current volume of 150.7 million shares is 972.43% of NanoVibronix...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

August 16, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy